Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1893)	9/25/2007 12:44:55 PM
From: Steve Lokness	Read Replies (5) \| Respond to of 3722

Bernard; Interesting "two" stocks you pick this morning; SQNM and CBMX. Are we into a paradigm switch in diagnostics? Throw in TWTI, CPHD and GHDX and this has been a sizzling sector. Ah, heck, throw in ILMN too? Is there a SI site that follows this sector? There should be. steve

To: Jibacoa who wrote (1893)	10/1/2007 10:41:56 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SQNM Has continued its up-move. (I would be satisfied with just 1%/day <g>) bigcharts.marketwatch.com It seems that the license rights they got grom Harvard have good potential.<g> This technology recently received a National Institutes of Health (NIH) three-year award for the development of a next-generation sequencing technology aiming at a sub-thousand dollar genome. Nanopore-based single molecule readout technology is a method that can detect a single strand of DNA as it passes through a pore that is more than a thousand times smaller than the diameter of a human hair and should enable ultra-high throughput DNA analysis such as sequencing, genotyping, and RNA and epigenetic analysis on a whole genome scale. Financial terms of the agreement include up-front fees, milestone payments and royalties on future product sales. And the stock has plenty of room to run.<g> bigcharts.marketwatch.com Bernard